His primary areas of study are Internal medicine, Endocrinology, Acromegaly, Hormone and Somatostatin. Lawrence A. Frohman regularly links together related areas like Loss of heterozygosity in his Internal medicine studies. His work on Endocrinology deals in particular with Growth hormone secretion, Hypothalamus, Growth hormone–releasing hormone, Peptide hormone and Insulin.
His Acromegaly research is multidisciplinary, incorporating perspectives in Tumor suppressor gene, Complication, Chemotherapy and Adenoma. His studies in Hormone integrate themes in fields like Secretion and Stimulation. His biological study deals with issues like Anterior pituitary, which deal with fields such as Gonadotropic cell.
Lawrence A. Frohman mainly investigates Internal medicine, Endocrinology, Somatostatin, Hormone and Growth hormone secretion. All of his Internal medicine and Acromegaly, Peptide hormone, Somatropin, Secretion and Receptor investigations are sub-components of the entire Internal medicine study. Hypothalamus, Pituitary gland, Growth hormone–releasing hormone, Somatotropic cell and Insulin are subfields of Endocrinology in which his conducts study.
His Somatostatin research is multidisciplinary, incorporating elements of Neuropeptide, Growth factor, Somatomedin and Gonadotropic cell. Lawrence A. Frohman has included themes like Messenger RNA and Thyroid in his Hormone study. His Growth hormone secretion research includes themes of Thyrotropin-releasing hormone, Blood sampling and Stimulation.
His scientific interests lie mostly in Internal medicine, Endocrinology, Acromegaly, Growth hormone secretion and Context. In Internal medicine, Lawrence A. Frohman works on issues like Gastroenterology, which are connected to Octreotide acetate. His study in Hormone, CJC-1295, Growth hormone–releasing hormone, Somatostatin and Pituitary gland falls under the purview of Endocrinology.
Lawrence A. Frohman has researched Growth hormone–releasing hormone in several fields, including Receptor and Somatotropic cell. His Somatostatin research is multidisciplinary, relying on both Hypothalamic Hormones and Argument. His Acromegaly study combines topics from a wide range of disciplines, such as Multiple endocrine neoplasia, Octreotide, Cell growth and Pathology.
His primary scientific interests are in Internal medicine, Endocrinology, Acromegaly, Context and Pituitary adenoma. His CJC-1295, Pituitary gland, Hormone, Growth hormone secretion and Clinical trial investigations are all subjects of Internal medicine research. His biological study spans a wide range of topics, including Hypothalamus, Pulsatile flow, Hormone analog, Blood sampling and Peptide hormone.
The various areas that Lawrence A. Frohman examines in his Endocrinology study include Multiple endocrine neoplasia and Prior Radiotherapy. His Acromegaly study combines topics in areas such as Alternative medicine and MEDLINE. His Pituitary adenoma research focuses on Tumor suppressor gene and how it connects with MEN1, HEK 293 cells and Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Secretagogues and the somatotrope: signaling and proliferation.
L A Frohman;R D Kineman;J Kamegai;S Park.
Recent Progress in Hormone Research (2000)
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Kip1
Hiroaki Kiyokawa;Rhonda D Kineman;Katia O Manova-Todorova;Vera C Soares.
Criteria for cure of acromegaly: a consensus statement.
Andrea Giustina;Ariel Barkan;Felipe F. Casanueva;Franco Cavagnini.
The Journal of Clinical Endocrinology and Metabolism (2000)
Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary
Michael Berelowitz;Marta Szabo;Lawrence A. Frohman;Susan Firestone.
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.
Timothy Williams;Michael Berelowitz;Stephen N. Joffe;Michael O. Thorner.
The New England Journal of Medicine (1984)
Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients.
M. J. Favus;A. B. Schneider;M. E. Stachura;J. E. Arnold.
The New England Journal of Medicine (1976)
Growth Hormone-Releasing Hormone
Lawrence A. Frohman;John-Olov Jansson.
Endocrine Reviews (1986)
Guidelines for Acromegaly Management
S. Melmed;F. F. Casanueva;F. Cavagnini;P. Chanson.
The Journal of Clinical Endocrinology and Metabolism (2002)
Octreotide Treatment of Acromegaly: A Randomized, Multicenter Study
Shereen Ezzat;Peter J. Snyder;William Francis Young;Louis D. Boyajy.
Annals of Internal Medicine (1992)
Safety and efficacy of long-term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients—a clinical research center study
Connie B. Newman;Shlomo Melmed;Peter J. Snyder;William F. Young.
The Journal of Clinical Endocrinology and Metabolism (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: